Biohaven Pharma (BHVN) PT Lowered to $22 at RBC Capital
RBC Capital analyst Leonid Timashev ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)